Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade

Shares of Tarsus Pharmaceuticals, Inc. (TARS) have gained 22.4% over the past four weeks to close the last trading session at $44.83, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$63.25 indicates a potential upside of 41.1%.The average comprises eight short-term price targets ranging from a low of $41 to a high of$84, with a standard deviation of $13.65. While the lowest est ...